Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. 2004

Anne M Kenny, and Geraldine Fabregas, and Chaewon Song, and Bradley Biskup, and Sandra Bellantonio
Center on Aging, MC-5215, University of Connecticut Health Center, Farmington, CT 06030-5215, USA. kenny@nso1.uchc.edu

BACKGROUND The role of sex hormones in the prevention of cognitive decline is uncertain. Animal studies suggest mechanisms for sex hormones including testosterone to maintain optimal cognitive function. But, there are studies to suggest that endogenous testosterone levels are associated with aggression in men with cognitive impairment. METHODS In this pilot study, 11 men (mean age 80 +/- 5 years, range 73-87 years) with early cognitive decline and bioavailable testosterone levels below 128 ng/dl (lower limit for adult normal range) were randomized to receive intramuscular testosterone (200 mg every 3 weeks) or placebo for 12 weeks. Outcome measures included sex hormones (testosterone, bioavailable testosterone, sex hormone binding globulin, estradiol, and estrone), Behave AD Questionnaire, Katz Activities of Daily Living, Geriatric Depression Scale, Digit Span, Clock Face Drawing, Clock Face Perception, Verbal Fluency, Trail-Making B, and International Prostate Symptom Score at baseline, 4 weeks, and 10 weeks. RESULTS All men completed the study. Total and bioavailable testosterone, estrone, and estradiol levels increased in men receiving testosterone, but no changes were detected in men receiving placebo. No significant changes were found in behavior following testosterone supplementation, nor was there evidence of change in depression or activities of daily living. No discernable changes were found in any of the cognitive tests. Symptoms of prostate hyperplasia remained unchanged in the testosterone (6.6 + 5.8 to 5.2 + 3.6; p =.39) and placebo (8.8 + 6.4 to 6.4 + 3.8; p =.15) groups, and prostate-specific antigen levels did not change significantly. CONCLUSIONS No significant changes in behavior, function, depression, or cognitive performance occurred following 12 weeks of testosterone replacement in men with low testosterone levels and early-to-moderate cognitive impairment. This pilot work suggests that testosterone can be given to men with early cognitive impairment without significant concern about worsening aggressive or unwanted behaviors.

UI MeSH Term Description Entries
D008297 Male Males
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D001519 Behavior The observable response of a man or animal to a situation. Acceptance Process,Acceptance Processes,Behaviors,Process, Acceptance,Processes, Acceptance
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity

Related Publications

Anne M Kenny, and Geraldine Fabregas, and Chaewon Song, and Bradley Biskup, and Sandra Bellantonio
July 2010, Journal of the American Geriatrics Society,
Anne M Kenny, and Geraldine Fabregas, and Chaewon Song, and Bradley Biskup, and Sandra Bellantonio
May 2002, The journals of gerontology. Series A, Biological sciences and medical sciences,
Anne M Kenny, and Geraldine Fabregas, and Chaewon Song, and Bradley Biskup, and Sandra Bellantonio
January 2001, Neuropsychologia,
Anne M Kenny, and Geraldine Fabregas, and Chaewon Song, and Bradley Biskup, and Sandra Bellantonio
January 2016, CNS & neurological disorders drug targets,
Anne M Kenny, and Geraldine Fabregas, and Chaewon Song, and Bradley Biskup, and Sandra Bellantonio
February 2017, JAMA,
Anne M Kenny, and Geraldine Fabregas, and Chaewon Song, and Bradley Biskup, and Sandra Bellantonio
June 2015, American journal of Alzheimer's disease and other dementias,
Anne M Kenny, and Geraldine Fabregas, and Chaewon Song, and Bradley Biskup, and Sandra Bellantonio
January 2014, Clinical interventions in aging,
Anne M Kenny, and Geraldine Fabregas, and Chaewon Song, and Bradley Biskup, and Sandra Bellantonio
December 2018, Journal of applied physiology (Bethesda, Md. : 1985),
Anne M Kenny, and Geraldine Fabregas, and Chaewon Song, and Bradley Biskup, and Sandra Bellantonio
April 2008, Clinical endocrinology,
Anne M Kenny, and Geraldine Fabregas, and Chaewon Song, and Bradley Biskup, and Sandra Bellantonio
March 2023, Archives of gerontology and geriatrics,
Copied contents to your clipboard!